New COVID-19 oral treatment on PBS
From May 1, the second, prescription-only, COVID-19 oral treatment will be available on the Pharmaceutical Benefits Scheme (PBS) for Australians at high risk of developing severe COVID-19. Paxlovid® (nirmatrelvir + ritonavir) is an oral anti-viral medicine which can be used by patients with mild to moderate COVID-19 who are at high risk of developing…
Details